BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26798059)

  • 21. Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.
    Lee EJ; Park HW; Jeon HJ; Kim HS; Chang MS
    Regen Med; 2013 May; 8(3):283-93. PubMed ID: 23627823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
    Litwin M; Radwańska A; Paprocka M; Kieda C; Dobosz T; Witkiewicz W; Baczyńska D
    Mol Cell Biochem; 2015 Dec; 410(1-2):131-42. PubMed ID: 26314253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iloprost up-regulates vascular endothelial growth factor expression in human dental pulp cells in vitro and enhances pulpal blood flow in vivo.
    Limjeerajarus CN; Osathanon T; Manokawinchoke J; Pavasant P
    J Endod; 2014 Jul; 40(7):925-30. PubMed ID: 24935537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Human Deciduous Dental Pulp-Derived Mesenchymal Stem Cell-Derived Conditioned Medium on the Metabolism of HUVECs, Osteoblasts, and BMSCs.
    Kunimatsu R; Hiraki T; Rikitake K; Nakajima K; Putranti NAR; Abe T; Ando K; Nakatani A; Sakata S; Tanimoto K
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators.
    Santos TC; Morton TJ; Moritz M; Pfeifer S; Reise K; Marques AP; Castro AG; Reis RL; van Griensven M
    Tissue Eng Part A; 2013 Apr; 19(7-8):834-48. PubMed ID: 23173745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Therapeutic Potential of Dual 3D Mesenchymal Stem Cell Therapy in an Ischemic Hind Limb Mouse Model.
    Chae DS; An SJ; Han S; Kim SW
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Severe In Vitro Hypoxia Exposure Enhances the Vascularization Potential of Human Adipose Tissue-Derived Stromal Vascular Fraction Cell Engineered Tissues.
    Mytsyk M; Cerino G; Reid G; Sole LG; Eckstein FS; Santer D; Marsano A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
    Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
    J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds.
    Kampmann A; Lindhorst D; Schumann P; Zimmerer R; Kokemüller H; Rücker M; Gellrich NC; Tavassol F
    Microvasc Res; 2013 Nov; 90():71-9. PubMed ID: 23899416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation.
    Pedersen TO; Blois AL; Xue Y; Xing Z; Sun Y; Finne-Wistrand A; Lorens JB; Fristad I; Leknes KN; Mustafa K
    Stem Cell Res Ther; 2014 Feb; 5(1):23. PubMed ID: 24533904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures.
    Nishiguchi A; Matsusaki M; Asano Y; Shimoda H; Akashi M
    Biomaterials; 2014 Jun; 35(17):4739-48. PubMed ID: 24655783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation.
    Weil BR; Abarbanell AM; Herrmann JL; Wang Y; Meldrum DR
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1735-43. PubMed ID: 19386985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product.
    Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide suppresses the secretion of vascular endothelial growth factor and hepatocyte growth factor from human mesenchymal stem cells.
    Wang Y; Crisostomo PR; Wang M; Weil B; Abarbanell A; Poynter J; Manukyan MC; Meldrum DR
    Shock; 2008 Nov; 30(5):527-31. PubMed ID: 18391852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of three inducing factors on differentiation of bone marrow derived mesenchymal stem cells into lymphatic endothelial cells].
    Wang YH; Xue B
    Zhonghua Shao Shang Za Zhi; 2019 Feb; 35(2):125-133. PubMed ID: 30798579
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.
    Liu L; Gao J; Yuan Y; Chang Q; Liao Y; Lu F
    Cell Biol Int; 2013 Jun; 37(6):551-60. PubMed ID: 23505143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow-derived mesenchymal stem cells.
    Kunimatsu R; Nakajima K; Awada T; Tsuka Y; Abe T; Ando K; Hiraki T; Kimura A; Tanimoto K
    Biochem Biophys Res Commun; 2018 Jun; 501(1):193-198. PubMed ID: 29730288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of FGF-2 on stem cells from inflamed dental pulp tissue from human deciduous teeth.
    Kim J; Park JC; Kim SH; Im GI; Kim BS; Lee JB; Choi EY; Song JS; Cho KS; Kim CS
    Oral Dis; 2014 Mar; 20(2):191-204. PubMed ID: 23496287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-rich plasma improves the therapeutic efficacy of mesenchymal stem cells by enhancing their secretion of angiogenic factors in a combined radiation and wound injury model.
    Myung H; Jang H; Myung JK; Lee C; Lee J; Kang J; Jang WS; Lee SJ; Kim H; Kim HY; Park S; Shim S
    Exp Dermatol; 2020 Feb; 29(2):158-167. PubMed ID: 31560791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.